EMA communication: Human medicines: highlights of 2016
The European Medicines Agency has published an overview of its key recommendations of 2016 in relation to the marketing authorisations of new medicines and the safety monitoring of authorised medicines. In 2016, EMA recommended 81 medicines for marketing authorisation, including 27 new active substances.
A selection of these recommendations can be found in the human medicines highlights document available by clicking here.
For more information on the European regulatory system for medicines, please consult our brochure.
We would be grateful if you could disseminate this email to anyone else who might be interested in this information.
With kind regards,
Stakeholders and Communication Division
European Medicines Agency
30 Churchill Place
London, E14 5EU